APA (7th ed.) Citation

FR, M. C., M, V., B, C., M, G., PS, J., MM, M., . . . SD, S. (2025). Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial. JACC. Heart failure, 13(1), 105. https://doi.org/10.1016/j.jchf.2024.08.022

Chicago Style (17th ed.) Citation

FR, Mc Causland, et al. "Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial." JACC. Heart Failure 13, no. 1 (2025): 105. https://doi.org/10.1016/j.jchf.2024.08.022.

MLA (9th ed.) Citation

FR, Mc Causland, et al. "Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial." JACC. Heart Failure, vol. 13, no. 1, 2025, p. 105, https://doi.org/10.1016/j.jchf.2024.08.022.